CoImmune, fka Argos Therapeutics, is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases. Using biological components from each patient, the company's immunotherapies employ the patient's dendritic cells to activate an immune response specific to the patient's disease.

CoImmune

The development of CD83 is part of Argos Therapeutics ' research and development collaboration with its Canadian partner , DC Bio ... .

Argos Therapeutics Presents Positive Transplantation and Immunosuppression Data for Soluble CD83 at the American Transplant Congress - Lumira

Other Investors

DC Biosciences, formerly Dundee Cell Products, provides pharmaceutical and biotech companies with novel technologies and proteomics services to accelerate the development of safer drugs.

DC Biosciences

Discovery Investment Fund

Promega is engaged in applying biochemistry and molecular biology to the development of high-value biological reagents and systems for the life sciences industry.

Co-Diagnostics (NASDAQ: CODX) is a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), and to sell diagnostic equipment from other manufacturers as self-contained lab systems ("MDx device").

Dwight Egan

Bio-IT World | University of Missouri researchers developed an innovative method using nanopores; Oxford Nanopore speeds basecalling for MinKNOW;  Standigm and Nashville Biosciences partner on early drug discovery research, and more.

Nanopore News from Oxford Nanopore, University of Missouri, New Genedata Product, More

Size to Top USD 1.763 Billion with 8.89% CAGR by 2030
[201 + Pages Research Study] According to a market research study published by Zion Market Research, the demand analysis of Global Spectroscopy Software Market size & share revenue was valued at around USD 971.48 Million in 2022 and is estimated to grow about USD 1,763.28 million by 2030, at a CAGR of approximately 8.89% between 2023 and 2030. The key market players are listed in the report with their sales, revenues and strategies are Waters Corp, Shimadzu, Microsaic Systems, Agilent Technologies, OpenMS, Genedata AG, MS Wil B.V, Adaptas Solutions, SpectralWorks, Advanced Chemistry Development, Lablicate GmbH, Thermo Fisher Scientific, Bruker, Danaher Corporation, and others. July 29, 2023 13:46 ET
Sarasota, Florida, UNITED STATES
Houston, TX, July  29, 2023  (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Spectroscopy Software Market By Deployment Mode (On-Premise And Cloud), By Application (Food Testing And Environmental Testing) Key Players (Microsaic Systems Plc, Thermo Fisher Scientific Inc. Shimadzu Scientific Instruments, Genedata AG...) And By Region: - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2023 - 2030” in its research database. “According to the latest research study, the demand for global Spectroscopy Software Market size & share in terms of revenue was valued at USD 971.48 Million in 2022 and it is expected to surpass around USD 1,763.28 million mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 8.89% during the forecast period 2023 to 2030.”
What is/are Spectroscopy Software? How big is the Spectroscopy Software Industry? Spectroscopy software is a software application or computer program that has been developed specifically for the purpose of analyzing and interpreting spectroscopic data. Spectroscopy is a method that involves the study of the interaction between matter and electromagnetic radiation. It is an extremely useful tool that can provide information about the structure, composition, and characteristics of a wide variety of different substances. Researchers, scientists, and engineers working in a wide variety of subjects, including as chemistry, physics, biology, astronomy, and materials science, need to have access to these software tools in order to be successful in their job. They help in processing, visualizing, and interpreting spectral data obtained from various spectroscopic techniques like:
Nuclear Magnetic Resonance (NMR) Spectroscopy: Utilized in the process of determining the structure as well as the dynamics of molecules. Spectral processing, peak selecting, integration, and chemical shift assignment are all made easier with the assistance of NMR software. Mass Spectrometry (MS): MS software provides assistance in the analysis of mass spectra, which is necessary in order to recognize and quantify the chemical components that are present in a sample. Infrared (IR) Spectroscopy: Software designed for IR spectroscopy is used to process and interpret infrared spectra, which provides information on functional groups and chemical structures. UV-Visible (UV-Vis) Spectroscopy: The analysis of absorbance spectra is a common method for determining the amount of analytes present in a sample. UV-Vis software can be used to assist in this process. Raman Spectroscopy: The processing of Raman spectra by software designed specifically for Raman spectroscopy reveals information about molecules' vibrations as well as rotations. Fluorescence Spectroscopy: The analysis of fluorescence emission spectra is a technique that is frequently applied in chemistry and biology research, and this software is designed to do those analyses. X-ray Photoelectron Spectroscopy (XPS): The elemental composition of a material's surface can be determined using XPS software, which assists in the analysis of X-ray photoelectron spectra to detect the chemical state of the surface. Atomic Absorption Spectroscopy (AAS): For the purpose of elemental analysis, AAS software is utilized by measuring the amount of light absorbed by atoms in their ground states within a flame or graphite furnace. Circular Dichroism (CD) Spectroscopy: CD spectroscopy software performs an analysis of the differential absorption of left and right circularly polarized light. This analysis is beneficial for the investigation of the secondary structures of biomolecules. Magnetic Resonance Imaging (MRI): The processing and interpretation of imaging data generated from nuclear magnetic resonance using MRI software results in the production of detailed images of various organs and tissues. Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs -  https://www.zionmarketresearch.com/sample/spectroscopy-software-market
(A free sample of this report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the Following:
Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
About 201+ Pages Research Report (Including Recent Research)
Provide detailed chapter-by-chapter guidance on Request
Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
Includes Tables and figures have been updated
The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Zion Market Research research methodology
Spectroscopy Software Report Coverage & Overview:
Spectroscopy investigates how light interacts with matter and finds application in determining functional groups and structures in organic compounds. Several types of spectroscopy exist, including infrared spectroscopy, UV/Vis spectroscopy, and Proton NMR spectroscopy. These diverse spectroscopic techniques play a crucial role in various scientific domains, including biomedical sciences, space exploration, and environmental analysis. Spectroscopy software fosters collaboration, improves data accessibility, and offers solutions for visualizing, processing, and managing spectroscopy data. (Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.) Global Spectroscopy Software Market: Growth Dynamics
The key aspects that are driving the expansion of the global spectroscopy software market are the growing demand for research and development, the increasing trend of integrating automation in laboratories, and the rising prevalence of the use of spectroscopy in an increasing number of therapeutic and diagnostic procedures. The high potential of the software to raise the accuracy of test findings while simultaneously reducing the danger of errors caused by human intervention is another factor that is fueling the expansion of the market. In addition, spectroscopy is one of the most important methods utilized in the field of astronomy. This method allows for the collection of data concerning an astronomical object's density, composition, temperature, and various other physical processes. In such a scenario, the spectroscopic software not only assists in the generation of accurate and trustworthy findings, but it also provides a user interface that is simple to use. In addition, the increasing adoption of spectroscopy software to satisfy the requirements set for quality in food testing as well as environmental analysis is fueling the growth of the market. Spectroscopy software is used to analyze the spectrum of light emitted by an object. In the next years, the expansion of the market will be driven by factors such as the simplicity of deploying spectroscopic software and the intensifying competition among the leading firms to develop more advanced software. Nevertheless, the expansion of the market will be hampered by a scarcity of experts who are skilled and have a high level of training. As a result of the emergence of covid-19, the hospitals and clinics are dealing with significant difficulties. Because the disease has affected millions of people all over the world, the healthcare industry does not have the resources to provide appropriate treatment and precise diagnosis. Spectroscopy and the sophisticated technologies that it employs are at the heart of its pioneering uses in the medical industry. Infectious disease can be more accurately diagnosed with the use of infrared and Raman spectroscopy. In addition, it has developed as a valuable biomedical tool for the monitoring of human diseases as well as the early diagnosis of certain disorders. Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/prebook/su/spectroscopy-software-market
Report Scope

Foreseen Advancements: Global Spectroscopy Software Market Size to Top USD 1.763 Billion with 8.89% CAGR by 2030

Biosimulation Market: Competition Insights
The key companies operating in the biosimulation market include Certara, Dassault Systemes, Advanced Chemistry Development, Simulation Plus Inc., Schrodinger, Inc., Chemical Computing Group, Physiomics Plc, Rosa & Co. LLC, BioSimulation Consulting Inc., Genedata AG, Instem Group of Companies, PPD, Inc., Insilico Biotechnology AG,  Rhenovia Pharma, LeadInvent Technologies, Nuventra Pharma, and In Silico  Biosciences. Some of the recent developments by key providers of biosimulation are as follows:
In June 2022, Certara announced its new version of Biosimulation software for the progress of Novel Biologics. The new version includes Immunogenicity (IG), Immuno-Oncology (IO), and Vaccine simulators to understand and predict how drugs work and point out the key questions in the development of novel biologic therapies. In June 2022, Genedata AG announced that Syros Pharmaceuticals has chosen Genedata AG’s Genedata Profiler as its data integration and investigative platform to accelerate its translational research strategy. In March 2022, Advanced Chemistry labs announced that Pharmaron Inc. has chosen its NMR processing and interpretation software. In March 2022, Simulation Plus, Inc. released its Membrane Plus 3.0 software. The new software includes improved data handling and simulation performance for in vitro-in vivo for extrapolation (IVIVE) for permeability, skin penetration, and release assay systems. In February 2022, the US Food and Drug Administration (FDA) approved the license for Certara’s Immunogenicity (IG) stimulator to research and assess immunogenicity in protein-based remedies. In February 2022, Physiomics Plc updated a new agreement with ValiRx plc. According to the new agreement, ValiRx will be able to use Physiomics Plc’s latest version of its Virtual Tumour technology. Physiomics Plc will also help ValiRx in modeling the use of VAL201 peptide in endometriosis (VAL301) and Coronavirus (BC201). Limited time Offer, Get Customization with 40% discount @ https://www.futuremarketinsights.com/customization-available/rep-gb-16031
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Biosimulation Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals essential insights by Product Type (Services (In-house services, Contract services), Software), by Deployment mode (Drug Development, Drug Discovery, Other Applications), by End-use (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions), across five regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa). Key Segments Covered in Biosimulation Industry Survey
Biosimulation Market by Product Type:
Services
Drug Development
Market Background
Have a Look at Related Research Reports of Healthcare Domain:
Bleeding Disorder Testing Market Size : The global bleeding disorder testing market is expected to garner a market value of US$ 95 Billion in 2023 and is expected to accumulate a market value of US$ 190 Billion by registering a CAGR of 7.2% in the forecast period 2023-2033. Treatment-Resistant Depression Treatment Market Trend : The global treatment-resistant depression treatment market size is expected to be valued at US$ 1.69 Billion in 2023. Nano Dentistry Market Growth : The global nano dentistry market was valued at US$ 838.54 Million in 2022 and is anticipated to achieve a market valuation of US$ 906.66 Million in 2023. Genomics Market Forecast : Newly-released Genomics industry analysis report by Future Market Insights shows that global sales of Genomics in 2021 were held at US$ 24.3 Bn. With 19.8%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. Hair Restoration Market Analysis : Newly-released Hair Restoration industry analysis report by Future Market Insights shows that global sales of Hair Restoration in 2021 were held at US$ 4.9 Bn. With a CAGR of 18.2%, the projected market growth during 2022 - 2032
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries. Contact Us:

Global Biosimulation Market had crossed a worth of US$ 2.6 Bn in 2021, with a predicted CAGR of 21.5%; the market is estimated to reach revenue of US$ 20.9 Bn by year 2032-end | FMI

The global market for Biosimulation Technology estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$7.5 Billion by 2027, growing at a CAGR of 15.4% over the analysis period 2020-2027. Software, one of the segments analyzed in the report, is projected to record 14.4% CAGR and reach US$5.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 17.4% CAGR for the next 7-year period. The U.S. Market is Estimated at $806.8 Million, While China is Forecast to Grow at 14.8% CAGR
The Biosimulation Technology market in the U.S. is estimated at US$806.8 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 14.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.4% and 13% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.8% CAGR. Select Competitors (Total 22 Featured) -
3DS BIOVIA
Certara USA, Inc.

Global Biosimulation Technology Market Report 2022: Featuring 3DS BIOVIA, Advanced Chemistry Development, Certara USA, Genedata and Schrodinger Among Others - ResearchAndMarkets.com

Intellasia East Asia News DUBLIN--(BUSINESS WIRE)--The "Biosimulation Technology: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Biosimulation Technology estimated at US$2.8 Billion in the year 2020, is proje...

Global Biosimulation Technology Market Report 2022: Featuring 3DS BIOVIA, Advanced Chemistry Development, Certara USA, Genedata and Schrodinger Among Others – ResearchAndMarkets.com

Debiopharm Group is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. It in-licenses promising biologics and small molecule candidates. The group develops its products with a view to licensing them out to pharmaceutical partners for sales and marketing. The company was founded in 1979 and is based in Switzerland.

Debiopharm Group

Pioneer in advancing tomorrow 's standard of care to cure cancer and infectious diseases , Debiopharm selects Genedata , an industry-leading digital platform for translational and reverse translational research , as the cornerstone of its research and development strategy .

Debiopharm Partners with Genedata to Digitalize Translational Research - Debiopharm

Rijk Zwaan is a specialist in creating vegetables. IT does this through research and development.

Rijk Zwaan

`` We are excited about our partnership with Rijk Zwaan to digitalize their R&D processes and accelerate their breeding programs based on our Genedata platform '' , said Dr. Othmar Pfannes , CEO of Genedata .

Rijk Zwaan（ライク・ズワーン）社、Genedata Selectorを導入：高品質かつ革新的な野菜品種の開発を加速.

Icosagen develops technologies and conducts research and development programs for the biopharmaceutical, and biotechnology industries. It also offers services, such as protein production, antibody production, and VLP (Virus-like particles) production. The company was founded in 1999 and is based in Tartu, Estonia.

Icosagen

`` We are excited that Icosagen , a distinguished CRDMO , has chosen Genedata to digitalize their antibody operations , '' said Othmar Pfannes , Ph.D. , CEO of Genedata .

PRESS RELEASE: Icosagen Chooses Genedata Biologics to Digitalize Recombinant Antibody Discovery - Icosagen

DataHow specializes in data analytics and process modeling for the process industry in the biopharmaceutical and chemical domains. It offers digital solutions and engineering consulting for process screening, monitoring, optimization, control, and scale-up. It provides on-site and virtual training and workshops on specific data analytics, process modeling, and digitalization topics. DataHow was founded in 2017 and is based in Dubendorf, Switzerland.

DataHow

Light Chain Bioscience is a biotech company that focuses on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders and cancer.

Light Chain Bioscience

Series A

Genedata aims to provide computational solutions for drug discovery and systems biology research with a combination of software products and professional services that have been developed in partnership with major pharma and biotech companies.

Genedata

Novartis Venture Funds

BioDiscovery is engaged in the development of microarray bioinformatics software and services. On October 12th, 2021, BioDiscovery was acquired by BioNano Genomic at a valuation of $100M.

Ambry Genetics offers a comprehensive suite of genetic testing solutions for inherited and non-inherited diseases as well as for numerous clinical specialties, including oncology, cardiology, pulmonology, neurology, and general genetics. The company is recognized as a leader in diagnostic solutions for hereditary conditions in the United States, by having performed more than one million genetic tests and identified more than 45,000 mutations in at least 500 different genes. Ambry is known as a pioneer and thought leader in genetic testing being the first laboratory in the world to offer such tests as hereditary cancer panels and clinical exome sequencing.

Wells Fargo Success Story

Professional Services

Platform Overview

Compare DC Biosciences vs Genedata

Customers evaluate the quality of DC Biosciences's products using the following success metrics.